CDMO Cambrex likes its deals big or small. In September it closed the $425 million deal acquisition of Halo Pharma. This week it is buying a four-facility competitor in a $250 million deal.
There is more M&A action in the CDMO arena this week as New Jersey-based Cambrex has struck a deal to buy Halo Pharma, picking up two manufacturing facilities in the process.